Russia continues to pound Ukraine with missile strikes, often targeting infrastructure like power plants. That has caused ...

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

By sharing scientific progress and making it universally available, the world can achieve a future free from Aids. The fight ...

Dr. Greg Shay is a pediatric pulmonologist, a children's lung specialist, with the NGO MedGlobal who has just returned from a ...

The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...

But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking ...

Less than three hundred women had accessed the vaginal ring through that initiative by the end of August 2024. While Atwine says lenacapavir will be a game-changer in terms of reducing the burden of ...

Gilead Sciences has announced the outcomes from the randomised Phase III PURPOSE 2 trial evaluating lenacapavir for human immunodeficiency virus (HIV) prevention. The trial demonstrated a 96% ...

However, results from a recent Gilead-funded clinical trial (Purpose-2) led by physicians at Emory University and Grady Health System indicate that a twice-yearly injection of Lenacapavir offers a 96% ...

This can now be addressed with long-acting lenacapavir. This new six-monthly injection was shown to provide 100% protection to young women in South Africa in a large clinical trial. It is expected ...

Credit: New Africa/Shutterstock. Gilead Sciences has announced the outcomes from the randomised Phase III PURPOSE 2 trial evaluating lenacapavir for human immunodeficiency virus (HIV) prevention. The ...

Berlin, Nov. 28, (dpa/GNA) – Biannual vaccinations with the drug lenacapavir offers effective protection against HIV infection, according to phase-3 study data published on Wednesday in the New ...